Secondary analysis of the INSPIRE trial in idiopathic pulmonary fibrosis: in 483 plasma samples, about 30% had autoimmune disease-specific autoantibodies and ~10% had autoantibodies of unknown specificity, suggesting occult connective tissue disease-associated ILD.
Secondary analysisn = 483 plasma samples
Glassberg et al. Revisiting the INSPIRE trial: antibody profiling reveals high prevalence of occult autoimmunity